<div id="readability-page-1">03:58 PM EST, 12/10/2025 (MT Newswires) -- Health care stocks rose late Wednesday afternoon with the NYSE Health Care Index adding 1.6% and the State Street Health Care Select Sector SPDR ETF (XLV) gaining 1.4%.The iShares Biotechnology ETF (IBB) increased 1.3%.In corporate news, CVS Health ( CVS ) is entering 2026 with momentum and visibility into mid-teens earnings growth through 2028 on margin and operational improvements, RBC Capital Markets said. CVS shares rose 1%.Pfizer ( PFE ) plans to cut more than 200 jobs in Switzerland as part of its multiyear cost reduction program, Bloomberg reported. Pfizer ( PFE ) shares gained 1.7%.HeartBeam ( BEAT ) shares almost doubled after the company said the US Food and Drug Administration has granted a 510(k) clearance for its 12-lead electrocardiogram synthesis software for use at home or anywhere to assess arrhythmia.Centessa Pharmaceuticals ( CNTA ) is positioned to redefine narcolepsy treatment with its pipeline that includes best-in-class orexin agonists, Oppenheimer said, boosting its price target on the stock to $62 from $40. Centessa shares rose 3.5%. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.</div>

西維斯

CNTA

醫療保健股票在下午交易中上漲，紐約證券交易所醫療保健指數上漲 1.6%，State Street 醫療保健精選行業 SPDR ETF 上漲 1.4%。CVS Health 預計到 2028 年將實現中雙位數的盈利增長，推動其股價上漲 1%。輝瑞計劃在瑞士裁員，股價上漲 1.7%。HeartBeam 的股價在獲得 FDA 對其心電圖軟件的批准後幾乎翻倍。Centessa Pharmaceuticals 的股價在 Oppenheimer 上調目標價後上漲 3.5%

板塊更新：醫療保健類股在下午晚些時候上漲